312 related articles for article (PubMed ID: 31360087)
21. CD123 and More: How to Target the Cell Surface of Blastic Plasmacytoid Dendritic Cell Neoplasm.
Bôle-Richard E; Pemmaraju N; Caël B; Daguindau E; Lane AA
Cancers (Basel); 2022 May; 14(9):. PubMed ID: 35565416
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic and therapeutic advances in blastic plasmacytoid dendritic cell neoplasm: a focus on hematopoietic cell transplantation.
Kharfan-Dabaja MA; Lazarus HM; Nishihori T; Mahfouz RA; Hamadani M
Biol Blood Marrow Transplant; 2013 Jul; 19(7):1006-12. PubMed ID: 23396213
[TBL] [Abstract][Full Text] [Related]
23. Tagraxofusp as treatment for patients with blastic plasmacytoid dendritic cell neoplasm.
Lee SS; McCue D; Pemmaraju N
Expert Rev Anticancer Ther; 2020 Jul; 20(7):543-550. PubMed ID: 32460559
[TBL] [Abstract][Full Text] [Related]
24. An Unusual Manifestation of Blastic Plasmacytoid Dendritic Cell Neoplasm as a Testicular Tumor.
Pak DM; Tretiakova MS
Case Rep Pathol; 2019; 2019():9196167. PubMed ID: 31687245
[TBL] [Abstract][Full Text] [Related]
25. CD123-directed allogeneic chimeric-antigen receptor T-cell therapy (CAR-T) in blastic plasmacytoid dendritic cell neoplasm (BPDCN): Clinicopathological insights.
Pemmaraju N; Wilson NR; Senapati J; Economides MP; Guzman ML; Neelapu SS; Kazemimood R; Davis RE; Jain N; Khoury JD; Sugita M; Cai T; Smith J; Frattini MG; Garton A; Roboz G; Konopleva M
Leuk Res; 2022 Oct; 121():106928. PubMed ID: 35963025
[TBL] [Abstract][Full Text] [Related]
26. Blastic plasmacytoid dendritic cell neoplasm: A case report.
Wang W; Li W; Jia JJ; Zheng Y; Wang H; Gao XM; Dong XY; Tian Q; Jing HL; Wang X; Xiao SX
Oncol Lett; 2015 Mar; 9(3):1388-1392. PubMed ID: 25663917
[TBL] [Abstract][Full Text] [Related]
27. Updates in Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).
Economides MP; Rizzieri D; Pemmaraju N
Curr Hematol Malig Rep; 2019 Dec; 14(6):515-522. PubMed ID: 31853773
[TBL] [Abstract][Full Text] [Related]
28. Blastic Plasmacytoid Dendritic Cell Neoplasm: A Rapidly Progressive and Fatal Disease without Aggressive Intervention.
Prochaska L; Dakhil C; Mathur S
Clin Med Insights Case Rep; 2013; 6():201-4. PubMed ID: 24385715
[TBL] [Abstract][Full Text] [Related]
29. Relapse of tagraxofusp treated blastic plasmacytoid dendritic cell neoplasm with loss of CD123 expression.
Gulati R; Abu-Salah A; Salous T; Nassiri M
J Hematop; 2022 Mar; 15(1):35-39. PubMed ID: 38358597
[TBL] [Abstract][Full Text] [Related]
30. [Clinical Characteristics of CD4
He HS; Wei YF; Ji XY; Xu YH; Yang YQ; Jin XK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):588-594. PubMed ID: 38660871
[TBL] [Abstract][Full Text] [Related]
31. Blastic Plasmacytoid Dendritic Cell Neoplasm: State of the Art and Prospects.
Sapienza MR; Pileri A; Derenzini E; Melle F; Motta G; Fiori S; Calleri A; Pimpinelli N; Tabanelli V; Pileri S
Cancers (Basel); 2019 Apr; 11(5):. PubMed ID: 31035408
[TBL] [Abstract][Full Text] [Related]
32. Dendritic Cell Leukemia: a Review.
Tsagarakis NJ; Paterakis G
Curr Oncol Rep; 2020 May; 22(6):55. PubMed ID: 32415624
[TBL] [Abstract][Full Text] [Related]
33. Blastic Plasmacytoid Dendritic Cell Neoplasm.
Khoury JD
Curr Hematol Malig Rep; 2018 Dec; 13(6):477-483. PubMed ID: 30350260
[TBL] [Abstract][Full Text] [Related]
34. Blastic plasmacytoid dendritic cell neoplasm: diagnosis, manifestations, and treatment.
Sweet K
Curr Opin Hematol; 2020 Mar; 27(2):103-107. PubMed ID: 31972688
[TBL] [Abstract][Full Text] [Related]
35. Novel treatment of blastic plasmacytoid dendritic cell neoplasm: A case report.
Grushchak S; Joy C; Gray A; Opel D; Speiser J; Reserva J; Tung R; Smith SE
Medicine (Baltimore); 2017 Dec; 96(51):e9452. PubMed ID: 29390581
[TBL] [Abstract][Full Text] [Related]
36. Blastic plasmacytoid dendritic cell neoplasm: a single-center experience. Clinical characterization, mutational landscape, and clinical outcome of patients undergoing hematopoietic stem cell transplantation intensive therapy.
Gil-Lianes J; Mozas P; Baumann T; Combalia A; Baliu-Piqué C; García A; Rovira M; López-Guerra M; Villamor N; Colomer D; Rozman M; Esteve J; Estrach T
Actas Dermosifiliogr; 2024 Jun; ():. PubMed ID: 38852841
[TBL] [Abstract][Full Text] [Related]
37. Blastic plasmacytoid dendritic cell neoplasm: update on therapy especially novel agents.
Wang S; Wang X; Liu M; Bai O
Ann Hematol; 2018 Apr; 97(4):563-572. PubMed ID: 29455234
[TBL] [Abstract][Full Text] [Related]
38. Blastic Plasmocytoid Dendritic Cell Neoplasm (BPDCN): Clinical Features and Histopathology with a Therapeutic Overview.
Cazzato G; Capuzzolo M; Bellitti E; De Biasi G; Colagrande A; Mangialardi K; Gaudio F; Ingravallo G
Hematol Rep; 2023 Dec; 15(4):696-706. PubMed ID: 38132278
[TBL] [Abstract][Full Text] [Related]
39. Dual Expression of TCF4 and CD123 Is Highly Sensitive and Specific For Blastic Plasmacytoid Dendritic Cell Neoplasm.
Sukswai N; Aung PP; Yin CC; Li S; Wang W; Wang SA; Ortega V; Lyapichev K; Nagarajan P; Alfattal R; Angelova E; Tang Z; Loghavi S; Kanagal-Shamanna R; Miranda RN; Pemmaraju N; Bhalla K; Konopleva M; Medeiros LJ; Khoury JD
Am J Surg Pathol; 2019 Oct; 43(10):1429-1437. PubMed ID: 31261288
[TBL] [Abstract][Full Text] [Related]
40. A Rare Case of Blastic Plasmacytoid Dendritic Cell Neoplasm in a Child Mimicking Lymphoma/Leukemia Cutis.
Phusuphitchayanan P; Vejjabhinanta V; Takpradit C; Sudtikoonaseth P; Chairatchaneeboon M; Kiatvichukul T; Sukpanichnant S
Dermatopathology (Basel); 2022 Sep; 9(4):321-326. PubMed ID: 36278539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]